Clinical trial: Danish non-inferiority study of ocrelizumab and rituximab in MS: A randomized study comparing the efficacy of ocrelizumab
and rituximab in active multiple sclerosis

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514287-84-00?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20405

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology